164 related articles for article (PubMed ID: 35645665)
1. Risk of C1q variation in systemic lupus erythematosus: a meta-analysis with Trial Sequential Analysis.
Wang H; Wang T; Wang H; Wu Y; Wu L; Ling H; Ye DQ; Wang B
Postepy Dermatol Alergol; 2022 Apr; 39(2):353-361. PubMed ID: 35645665
[TBL] [Abstract][Full Text] [Related]
2. Association of rs172378 C1q gene cluster polymorphism with lupus nephritis in Bulgarian patients.
Radanova M; Vasilev V; Dimitrov T; Deliyska B; Ikonomov V; Ivanova D
Lupus; 2015 Mar; 24(3):280-9. PubMed ID: 25326229
[TBL] [Abstract][Full Text] [Related]
3. Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis.
Ebrahimiyan H; Mostafaei S; Aslani S; Faezi ST; Farhadi E; Jamshidi A; Mahmoudi M
Clin Exp Med; 2022 Aug; 22(3):427-438. PubMed ID: 34519938
[TBL] [Abstract][Full Text] [Related]
4. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
[TBL] [Abstract][Full Text] [Related]
5. Association Between C1q, TRAIL, and Tim-1 Gene Polymorphisms and Systemic Lupus Erythematosus.
Yu Y; Zhu C; Zhou S; Chi S
Genet Test Mol Biomarkers; 2018 Sep; 22(9):546-553. PubMed ID: 30183357
[TBL] [Abstract][Full Text] [Related]
6. Association of CTLA-4 (+49 A/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis.
Yu L; Shao M; Zhou T; Xie H; Wang F; Kong J; Xu S; Shuai Z; Pan F
Int Immunopharmacol; 2021 Jul; 96():107617. PubMed ID: 33866246
[TBL] [Abstract][Full Text] [Related]
7. The Association between Interleukin-6 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus: A Meta-analysis with Trial Sequential Analysis.
Liu J; Liao MQ; Cao DF; Yang Y; Yang Y; Liu YH; Zeng FF; Chen XH
Immunol Invest; 2021 Feb; 50(2-3):259-272. PubMed ID: 32573290
[TBL] [Abstract][Full Text] [Related]
8. Association of MBL-2 gene polymorphisms with systemic lupus erythematosus: an updated meta-analysis and trial sequential analysis.
Mahto H; Pati A; Sahu SK; Sharma HP; Padhi A; Panda AK
Lupus; 2020 Sep; 29(10):1227-1237. PubMed ID: 32635881
[TBL] [Abstract][Full Text] [Related]
9. C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis.
Mosaad YM; Hammad A; Fawzy Z; El-Refaaey A; Tawhid Z; Hammad EM; Youssef LF; ElAttar EA; Radwan DF; Fawzy IM
Clin Exp Immunol; 2015 Oct; 182(1):23-34. PubMed ID: 26095468
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 17A rs2275913 polymorphism is associated with susceptibility to systemic lupus erythematosus: A meta and trial sequential analysis.
Padhi S; Sarangi S; Nayak N; Barik D; Pati A; Panda AK
Lupus; 2022 May; 31(6):674-683. PubMed ID: 35353646
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis.
Wang T; Wang H; Qiu L; Wu L; Ling H; Xue Y; Zhou Y; Chen H; Ye DQ; Wang B
J Immunol Res; 2022; 2022():8140982. PubMed ID: 35469345
[TBL] [Abstract][Full Text] [Related]
12. Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC
Z Rheumatol; 2017 Oct; 76(8):708-715. PubMed ID: 27447696
[TBL] [Abstract][Full Text] [Related]
13. Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis.
Xiang N; Li XM; Wang GS; Tao JH; Li XP
Mol Biol Rep; 2013 Jan; 40(1):407-15. PubMed ID: 23065220
[TBL] [Abstract][Full Text] [Related]
14. Association of MBL2 gene polymorphisms and systemic lupus erythematosus susceptibility: A meta-analysis.
Yuan ZC; Xu WD; Lan YY; Wang JM; Wu Q; Zhou J; Huang AF
Int J Rheum Dis; 2021 Feb; 24(2):147-158. PubMed ID: 33146461
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against C1q in patients with systemic lupus erythematosus.
Trendelenburg M
Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-Converting Enzyme Gene I/D Polymorphism Is Associated With Systemic Lupus Erythematosus Susceptibility: An Updated Meta-Analysis and Trial Sequential Analysis.
Khan S; Dar SA; Mandal RK; Jawed A; Wahid M; Panda AK; Lohani M; Mishra BN; Akhter N; Haque S
Front Physiol; 2018; 9():1793. PubMed ID: 30618805
[TBL] [Abstract][Full Text] [Related]
17. Association of C1q gene cluster variants with rheumatoid arthritis: a pilot study.
Kosturkova MB; Mihaylova GM; Shivacheva TK; Radanova MA
Rheumatol Int; 2022 Jun; 42(6):1073-1083. PubMed ID: 35024943
[TBL] [Abstract][Full Text] [Related]
18. Association of Toll-Like Receptor 7 (TLR7) Polymorphisms with Predisposition to Systemic Lupus Erythematosus (SLE): A Meta and Trial Sequential Analysis.
Ranjan S; Panda AK
Biochem Genet; 2023 Dec; ():. PubMed ID: 38103124
[TBL] [Abstract][Full Text] [Related]
19. Associations between interleukin-10 gene polymorphisms and systemic lupus erythematosus risk: a meta-analysis with trial sequential analysis.
Yuan Y; Wang X; Ren L; Kong Y; Bai J; Yan Y
Clin Exp Rheumatol; 2019; 37(2):242-253. PubMed ID: 30183604
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against complement component C1q in systemic lupus erythematosus.
Trendelenburg M
Clin Transl Immunology; 2021; 10(4):e1279. PubMed ID: 33968409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
